ReviewActa pharmaceutica Sinica. B2021

Selective inhibition of CDK4/6: A safe and effective strategy for developing anticancer drugs.

Kai Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.